Elgethun Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.41M | Buy |
5,565
+184
| +3% | +$42.9K | 0.2% | 63 |
|
|
2026
Q1 | $1.32M | Buy |
5,381
+1,267
| +31% | +$295K | 0.22% | 56 |
|
|
2025
Q4 | $851K | Sell |
4,114
-49
| -1% | -$9.69K | 0.15% | 70 |
|
|
2025
Q3 | $770K | Buy |
4,163
+101
| +2% | +$17.3K | 0.14% | 69 |
|
|
2025
Q2 | $620K | Buy |
4,062
+239
| +6% | +$36.7K | 0.12% | 73 |
|
|
2025
Q1 | $634K | Buy |
3,823
+229
| +6% | +$35.8K | 0.14% | 70 |
|
|
2024
Q4 | $520K | Buy |
3,594
+140
| +4% | +$21.7K | 0.13% | 77 |
|
|
2024
Q3 | $560K | Sell |
3,454
-18,870
| -85% | -$3.01M | 0.13% | 74 |
|
|
2024
Q2 | $3.26M | Sell |
22,324
-63
| -0.3% | -$9.37K | 0.82% | 35 |
|
|
2024
Q1 | $3.51M | Buy |
22,387
+2,487
| +12% | +$396K | 0.89% | 33 |
|
|
2023
Q4 | $3.12M | Sell |
19,900
-839
| -4% | -$129K | 0.88% | 36 |
|
|
2023
Q3 | $3.22M | Sell |
20,739
-7,776
| -27% | -$1.28M | 0.97% | 33 |
|
|
2023
Q2 | $4.72M | Sell |
28,515
-280
| -1% | -$45.2K | 1.42% | 20 |
|
|
2023
Q1 | $4.47M | Sell |
28,795
-1,947
| -6% | -$314K | 1.42% | 20 |
|
|
2022
Q4 | $5.45M | Buy |
30,742
+186
| +0.6% | +$32.1K | 1.97% | 14 |
|
|
2022
Q3 | $4.99M | Buy |
30,556
+930
| +3% | +$157K | 2% | 12 |
|
|
2022
Q2 | $5.25M | Buy |
29,626
+209
| +0.7% | +$37.2K | 2.03% | 11 |
|
|
2022
Q1 | $5.21M | Buy |
29,417
+654
| +2% | +$111K | 1.77% | 14 |
|
|
2021
Q4 | $4.9M | Sell |
28,763
-713
| -2% | -$117K | 1.71% | 15 |
|
|
2021
Q3 | $4.76M | Buy |
29,476
+276
| +0.9% | +$47.1K | 1.64% | 17 |
|
|
2021
Q2 | $4.81M | Buy |
29,200
+492
| +2% | +$81.5K | 1.65% | 18 |
|
|
2021
Q1 | $4.72M | Buy |
28,708
+565
| +2% | +$91.4K | 1.84% | 15 |
|
|
2020
Q4 | $4.43M | Buy |
28,143
+515
| +2% | +$76K | 1.89% | 17 |
|
|
2020
Q3 | $4.11M | Sell |
27,628
-66
| -0.2% | -$9.77K | 2.25% | 11 |
|
|
2020
Q2 | $3.77M | Sell |
27,694
-3,207
| -10% | -$467K | 2.19% | 13 |
|
|
2020
Q1 | $4.05M | Buy |
30,901
+80
| +0.3% | +$11.3K | 2.25% | 12 |
|
|
2019
Q4 | $4.5M | Buy |
30,821
+18
| +0.1% | +$2.44K | 2.19% | 15 |
|
|
2019
Q3 | $4.01M | Buy |
30,803
+213
| +0.7% | +$28.1K | 2.14% | 15 |
|
|
2019
Q2 | $4.26M | Buy |
30,590
+63
| +0.2% | +$8.72K | 2.33% | 14 |
|
|
2019
Q1 | $4.27M | Sell |
30,527
-100
| -0.3% | -$13.4K | 2.49% | 9 |
|
|
2018
Q4 | $3.92M | Sell |
30,627
-2,784
| -8% | -$388K | 2.72% | 7 |
|
|
2018
Q3 | $4.64M | Buy |
33,411
+114
| +0.3% | +$15.1K | 3.01% | 5 |
|
|
2018
Q2 | $4.03M | Buy |
33,297
+1,343
| +4% | +$168K | 2.85% | 7 |
|
|
2018
Q1 | $4.09M | Buy |
31,954
+997
| +3% | +$135K | 2.86% | 4 |
|
|
2017
Q4 | $4.33M | Buy |
30,957
+722
| +2% | +$101K | 3.03% | 4 |
|
|
2017
Q3 | $3.93M | Buy |
30,235
+921
| +3% | +$122K | 2.89% | 6 |
|
|
2017
Q2 | $3.88M | Buy |
29,314
+101
| +0.3% | +$12.9K | 3.02% | 6 |
|
|
2017
Q1 | $3.64M | Buy |
29,213
+4,913
| +20% | +$587K | 2.92% | 9 |
|
|
2016
Q4 | $2.8M | Buy |
+24,300
| New | +$2.81M | 2.19% | 15 |
|
Other funds holding JNJ
AACR
ECSS
Elgethun Capital Management's JNJ Position: Q2 2026 in Review
Elgethun Capital Management increased its Johnson & Johnson (JNJ) stake by 3.4% in Q2 2026, buying an estimated $42.9K and bringing the position to 5,565 shares worth $1.41M. The position accounts for 0.2% of the portfolio, ranked #63.
Elgethun Capital Management first reported a position in JNJ in Q4 2016 and has held it in 39 quarters since. The position peaked at $5.45M in Q4 2022. 2,122 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Elgethun Capital Management held 5,565 shares of Johnson & Johnson worth $1.41M as of Q2 2026.
- Elgethun Capital Management bought 184 Johnson & Johnson shares in Q2 2026, an estimated $42.9K.
- Johnson & Johnson made up 0.2% of Elgethun Capital Management's portfolio in Q2 2026, its #63 holding.
- Elgethun Capital Management first reported a position in Johnson & Johnson in Q4 2016 and has held it in 39 quarters since.
- Elgethun Capital Management's Johnson & Johnson position peaked at $5.45M in Q4 2022.
- 2,122 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Elgethun Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.